Abstract |
Proton magnetic resonance spectroscopy (MRS) allows the noninvasive exploration of tissue metabolism in vivo, providing neurophysiological and neurochemical information. N-acetylaspartate (NAA) is generally considered to be a marker of neurons and axons, and many neurodegenerative disorders, including demyelinating disorders, exhibit a decrease in total NAA (tNAA). MRS in human hypomyelination disorders, such as Pelizaeus-Merzbacher disease (PMD), is characterized by normal to elevated tNAA, elevated myo- inositol and creatine (Cr), and normal to decreased choline (Cho). MRS in the thalamus of a hypomyelinating mouse model, a myelin synthesis-deficient (msd) mouse, a model of connatal PMD with mutation of the Plp1 gene, revealed increased tNAA and Cr and decreased Cho. That of a shiverer mouse with an autosomal recessive mutation of the Mbp gene showed decreased Cho with normal tNAA and Cr. Accordingly, the reduction of Cho on MRS might be a common marker for hypomyelinating disorders. tNAA concentrations range from normal to increased, probably depending upon the underlying pathology of oligodendrocytes. tNAA may be increased in hypomyelination with a reduced number of mature oligodendrocytes, such as PMD.
|
Authors | Jun-ichi Takanashi |
Journal | Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
(Magn Reson Med Sci)
Vol. 14
Issue 2
Pg. 85-91
( 2015)
ISSN: 1880-2206 [Electronic] Japan |
PMID | 26185828
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Aspartic Acid
- N-acetylaspartate
- Creatine
- Choline
|
Topics |
- Animals
- Aspartic Acid
(analogs & derivatives, analysis)
- Brain Chemistry
- Choline
(analysis)
- Creatine
(analysis)
- Demyelinating Diseases
(diagnosis)
- Disease Models, Animal
- Humans
- Mice
- Pelizaeus-Merzbacher Disease
(diagnosis)
- Proton Magnetic Resonance Spectroscopy
(methods)
|